Trial Profile
Colesevelam Oral Suspension as Monotherapy or Add-on to Metformin Therapy in Pediatric Subjects With Type 2 Diabetes Mellitus
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 20 Feb 2024
Price :
$35
*
At a glance
- Drugs Colesevelam (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms WELKid DM
- Sponsors Daiichi Sankyo Inc
- 14 Jul 2020 Status changed from active, no longer recruiting to completed.
- 22 May 2020 Planned End Date changed from 31 Mar 2020 to 30 Jun 2020.
- 10 Apr 2019 Planned End Date changed from 1 Jun 2019 to 31 Mar 2020.